AAAAAA

   
Results: << | 401-425 | 426-450 | 451-475 | 476-500 | >>

Table of contents of journal: *Hepatology

Results: 401-425/15678

Authors: Koike, Y Shiratori, Y Sato, S Obi, S Teratani, T Imamura, M Hamamura, K Imai, Y Yoshida, H Shiina, S Omata, M
Citation: Y. Koike et al., Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus - An analysis of 236 consecutive patients with a single lesion, HEPATOLOGY, 32(6), 2000, pp. 1216-1223

Authors: Arii, S Yamaoka, Y Futagawa, S Inoue, K Kobayashi, K Kojiro, M Makuuchi, M Nakamura, Y Okita, K Yamada, R
Citation: S. Arii et al., Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan, HEPATOLOGY, 32(6), 2000, pp. 1224-1229

Authors: Suzuki, A Zheng, YW Kondo, R Kusakabe, M Takada, Y Fukao, K Nakauchi, H Taniguchi, H
Citation: A. Suzuki et al., Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver, HEPATOLOGY, 32(6), 2000, pp. 1230-1239

Authors: Nakazawa, Y Jonsson, JR Walker, NI Kerlin, P Steadman, C Lynch, SV Strong, RW Clouston, AD
Citation: Y. Nakazawa et al., Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection, HEPATOLOGY, 32(6), 2000, pp. 1240-1247

Authors: Yoshiji, H Kuriyama, S Miyamoto, Y Thorgeirsson, UP Gomez, DE Kawata, M Yoshii, J Ikenaka, Y Noguchi, R Tsujinoue, H Nakatani, T Thorgeirsson, SS Fukui, H
Citation: H. Yoshiji et al., Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model, HEPATOLOGY, 32(6), 2000, pp. 1248-1254

Authors: Lehmann, TG Wheeler, MD Schwabe, RF Connor, HD Schoonhoven, R Bunzendahl, H Brenner, DA Samulski, RJ Zhong, Z Thurman, RG
Citation: Tg. Lehmann et al., Gene delivery of Cu/Zn-superoxide dismutase improves graft function after transplantation of fatty livers in the rat, HEPATOLOGY, 32(6), 2000, pp. 1255-1264

Authors: Strasser, SI Shulman, HM Flowers, ME Reddy, K Margolis, DA Prumbaum, M Seropian, SE McDonald, GB
Citation: Si. Strasser et al., Chronic graft-versus-host disease of the liver: Presentation as an acute hepatitis, HEPATOLOGY, 32(6), 2000, pp. 1265-1271

Authors: Nagaki, M Naiki, T Brenner, DA Osawa, Y Imose, M Hayashi, H Banno, Y Nakashima, S Moriwaki, H
Citation: M. Nagaki et al., Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not Fas-mediated apoptosis: Role of nuclear factor-kappa B, HEPATOLOGY, 32(6), 2000, pp. 1272-1279

Authors: Selzner, M Rudiger, HA Sindram, D Madden, J Clavien, PA
Citation: M. Selzner et al., Mechanisms of ischemic injury are different in the steatotic and normal rat liver, HEPATOLOGY, 32(6), 2000, pp. 1280-1288

Authors: Sewnath, ME Levels, HHM Elferink, RO van Noorden, CJF ten Kate, FJW van Deventer, SJH Gouma, DJ
Citation: Me. Sewnath et al., Endotoxin-induced mortality in bile duct-ligated rats after administrationof reconstituted high-density lipoprotein, HEPATOLOGY, 32(6), 2000, pp. 1289-1299

Authors: Shibuya, I Akaike, T Watanabe, Y
Citation: I. Shibuya et al., Design of a temporally and spatially controlled drug delivery system for the treatment of liver diseases in mice, HEPATOLOGY, 32(6), 2000, pp. 1300-1308

Authors: Jolley, CD Dietschy, JM Turley, SD
Citation: Cd. Jolley et al., Induction of bile acid synthesis by cholesterol and cholestyramine feedingis unimpaired in mice deficient in apolipoprotein AI, HEPATOLOGY, 32(6), 2000, pp. 1309-1316

Authors: Keitel, V Kartenbeck, J Nies, AT Spring, H Brom, M Keppler, D
Citation: V. Keitel et al., Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome, HEPATOLOGY, 32(6), 2000, pp. 1317-1328

Authors: Garcia-Villarreal, L Daniels, S Shaw, SH Cotton, D Galvin, M Geskes, J Bauer, P Sierra-Hernandez, A Buckler, A Tugores, A
Citation: L. Garcia-villarreal et al., High prevalence of the very rare Wilson disease gene mutation Leu708Pro inthe Island of Gran Canaria (Canary islands, Spain): A genetic and clinicalstudy, HEPATOLOGY, 32(6), 2000, pp. 1329-1336

Authors: Klomp, LWJ Bull, LN Knisely, AS van der Doelen, MAM Juijn, JA Berger, R Forget, S Nielsen, IM Eiberg, H Houwen, RHJ
Citation: Lwj. Klomp et al., A missense mutation in FIC1 is associated with Greenland familial cholestasis, HEPATOLOGY, 32(6), 2000, pp. 1337-1341

Authors: Roma, MG Milkiewicz, P Elias, E Coleman, R
Citation: Mg. Roma et al., Control by signaling modulators of the sorting of canalicular transportersin rat hepatocyte couplets: Role of the cytoskeleton, HEPATOLOGY, 32(6), 2000, pp. 1342-1356

Authors: Van Dyke, RW
Citation: Rw. Van Dyke, Effect of cholera toxin and cyclic adenosine monophosphate on fluid-phase endocytosis, distribution, and trafficking of endosomes in rat liver, HEPATOLOGY, 32(6), 2000, pp. 1357-1369

Authors: Ito, Y Matsui, T Kamiya, A Kinoshita, T Miyajima, A
Citation: Y. Ito et al., Retroviral gene transfer of signaling molecules into murine fetal hepatocytes defines distinct roles for the STAT3 and pas pathways during hepatic development, HEPATOLOGY, 32(6), 2000, pp. 1370-1376

Authors: Lietard, J Theret, N Rehn, M Musso, O Dargere, D Pihlajaniemi, T Clement, B
Citation: J. Lietard et al., The promoter of the long variant of collagen XVIII, the precursor of endostatin, contains liver-specific regulatory elements, HEPATOLOGY, 32(6), 2000, pp. 1377-1385

Authors: Berg, T Marques, AM Hohne, M Wiedenmann, B Hopf, U Schreier, E
Citation: T. Berg et al., Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment, HEPATOLOGY, 32(6), 2000, pp. 1386-1395

Authors: Keeffe, EB
Citation: Eb. Keeffe, Liver transplantation in patients with hepatic iron overload: Favorable orunfavorable outcome?, HEPATOLOGY, 32(6), 2000, pp. 1396-1398

Authors: Shafritz, DA
Citation: Da. Shafritz, Rat liver stem cells: Prospects for the future, HEPATOLOGY, 32(6), 2000, pp. 1399-1400

Authors: Poelstra, K
Citation: K. Poelstra, Towards controlled drug release in the liver, HEPATOLOGY, 32(6), 2000, pp. 1401-1402

Authors: Gianotti, N Uberti-Foppa, C Boeri, E Marinelli, M Tambussi, G Finazzi, R Lazzarin, A
Citation: N. Gianotti et al., Hepatitis B surface antigen clearance and appearance of antibodies againsthepatitis B surface antigen after treatment with recombinant interleukin 2in a human immunodeficiency virus-infected patient, HEPATOLOGY, 32(6), 2000, pp. 1409-1410

Authors: McCullen, MA Crawford, DHG Dimeski, G Tate, J Hickman, PE
Citation: Ma. Mccullen et al., Why there is discordance in reported decision thresholds for transferrin saturation when screening for hereditary hemochromatosis, HEPATOLOGY, 32(6), 2000, pp. 1410-1411
Risultati: << | 401-425 | 426-450 | 451-475 | 476-500 | >>